谷氨:癌症患者的光和阴影
Herbert Ryan Marini1, Bianca Arianna Facchini2, Raffaele di Francia3
1Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.
Biomedicines
|August 26, 2023
概括
谷氨 (GSH) 是一种对细胞健康至关重要的抗氧化剂. 虽然患者使用GSH来减少化疗副作用,但科学证据有限,除了西斯胺神经毒性. 医疗监督对于其使用至关重要.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞损伤增加了活性氧物种 (ROS),可能导致癌症发生.
- 谷氨 (GSH) 是一种关键的抗氧化剂,对于维持氧化还原平衡至关重要.
- 在癌症中,GSH扮演着复杂的角色,影响着外源生物的排毒和潜在的癌细胞保护.
研究的目的:
- 评估谷氨 (GSH) 在癌症患者中的作用和抗氧化作用.
- 审查关于GSH的临床和临床前研究,涉及饮食,毒性和癌症中的药理学过程.
- 为了澄清GSH和癌症之间的关系,特别是在化疗方面.
主要方法:
- 在Medline和EMBASE数据库上进行全面的文献搜索.
- 包括临床和临床前研究.
- 专注于研究GSH在癌症中的饮食,毒性和药理方面的研究.
主要成果:
- 通过生物激活,GSH与异生菌的结合可以减少它们的有害作用或通过生物激活增强毒性.
- GSH可能会保护癌细胞,作为一种潜在的武器来对抗化疗引起的毒性.
- 支持GSH在降低一般化疗毒性的有效性的证据很少,除了与西斯相关的神经毒性外.
结论:
- 癌症患者自给注射GSH以减轻治疗副作用缺乏强有力的科学支持,除了诸如西斯胺神经毒性等特定病例.
- 需要进一步的研究才能充分阐明GSH与癌症之间的复杂关系.
- 在癌症患者中使用GSH需要严格的医疗监督,考虑最佳时间和背景.
相关概念视频
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
257
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
257
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Sulfur Assimilation
38
Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
38
Electron Transport Chain: Complex I and II
14.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556


